Sònia Guedan
Research group
- Cellular immunotherapies for cancer Junior group leader (R3B)
About me
During the past 15 years I focused on developing novel therapies for the treatment of cancer. I first designed an oncolytic virus able to degrade the extracellular matrix of solid tumors, that is now under clinical investigation. In 2010, I moved to the University of Pennsylvania to develop novel chimeric antigen receptor-modified T cells (CAR-T) for the treatment cancer. My current research is focused on understanding the obstacles that lead to treatment failure and developing strategies to overcome these hurdles, with the ultimate goal of moving CAR-T cells for solid tumors into the clinic.
Featured publications
-
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Authors:Reference: Journal For Immunotherapy Of Cancer 2022. -
An NK-like CAR T cell transition in CAR T cell dysfunction
Authors:Reference: Cell 2021. -
Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer
Authors:Reference: Esmo Open 2021. -
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
Authors:Reference: Journal Of Clinical Investigation 2020. -
Engineering and Design of Chimeric Antigen Receptors
Authors:Reference: Molecular Therapy-Methods & Clinical Development 2019. -
Emerging Cellular Therapies for Cancer
Authors:Reference: Annual Review Of Immunology 2019. -
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager.
Authors:Reference: Cancer Immunology Research 2018. -
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Authors:Reference: Jci Insight 2018. -
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Authors:Reference: Immunity 2016. -
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Authors:Reference: Molecular Therapy 2010.
Featured Projects
-
Fine-tuning T cell networks of exhaustion by synthetic sensors
Principal investigator: Sònia Guedan CarrióFunder: European CommissionCode: HORIZON-EIC-2021-PathfinderDuration: 01/09/2022 - 30/08/2026 -
Development of enabling technologies for T-cell immunotherapy
Principal investigator: Sònia Guedan CarrióFunder: Fundación La CaixaCode: Health Research_2021Duration: 01/10/2021 - 30/09/2024 -
T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy
Principal investigator: Sònia Guedan CarrióFunder: European CommissionCode: CE_IMI12_18th_2stgDuration: 01/01/2021 - 31/12/2025 -
CAR-T cells as drug delivery agents for the treatment of solid tumors
Principal investigator: Sònia Guedan CarrióFunder: Asociación Española Contra el CáncerCode: AECC_Lab20Duration: 01/12/2020 - 29/02/2024 -
Chimeric Antigen Receptor (CAR)-modified T cells for the treatment of solid tumours
Principal investigator: Sònia Guedan CarrióFunder: Agencia Estatal de Investigacion (AEI)Code: PID2019-109546RA-I00Duration: 01/06/2020 - 31/05/2023